SD Biosensor

SD Biosensor Debt

The Debt of SD Biosensor (137310.KS) as of Nov 20, 2026 is 346.85 B KRW. In the previous year, Debt was 586.30 B KRW — a change of -40.84% (lower).

Debt

346.85 BKRW

YoY

-40.84%

Last updated:

In 2025, SD Biosensor's total debt was 346.85 B KRW, a -40.84% change from the 586.30 B KRW total debt recorded in the previous year.

The SD Biosensor Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2019
2.04 B KRW
Jan 1, 2021
274.92 M KRW
Jan 1, 2022
147.43 M KRW
Jan 1, 2023
461.83 B KRW
Jan 1, 2024
586.30 B KRW
Jan 1, 2025
346.85 B KRW
The SD Biosensor Debt history
YEARDebtYoY
346.85 BKRW-40.84%
586.30 BKRW+26.95%
461.83 BKRW+313,147.58%
147.43 MKRW-46.37%
274.92 MKRW-86.52%
2.04 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SD Biosensor Stock analysis

What does SD Biosensor do? SD Biosensor Inc generates revenue through the development and manufacturing of cholesterol and blood glucose testing equipment. The company sells rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, and enzyme immunological reaction diagnosis products. These products are distributed domestically and internationally, targeting healthcare providers and consumers in the immunochemical, molecular, and point-of-care diagnosis sectors. The firm focuses on self blood glucose measurement and other diagnostic solutions for medical use. The company's product portfolio includes POCTs, which are used for point-of-care testing in medical settings. SD Biosensor Inc's offerings serve both the domestic market and overseas markets, with a strong emphasis on diagnostic equipment for healthcare applications. Their business model relies on the sale of these specialized medical devices to hospitals, clinics, and individual consumers seeking home health monitoring solutions. Revenue streams are derived from the research, development, and sale of diagnostic products, including immunochemical and molecular diagnosis tools. The firm's products are designed for use in clinical and self-testing environments, supporting both professional healthcare services and personal health management. SD Biosensor Inc's market segments include healthcare institutions and end-users requiring diagnostic testing for cholesterol, blood glucose, and other medical conditions. SD Biosensor is one of the most popular companies on Eulerpool.

Debt Details

Understanding SD Biosensor's Debt Structure

SD Biosensor's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing SD Biosensor's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to SD Biosensor’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in SD Biosensor’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about SD Biosensor stock

Debt of SD Biosensor is 346.85 B KRW in 2025.

Debt of SD Biosensor changed from 586.30 B KRW to 346.85 B KRW, representing a -40.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt SD Biosensor since 2006 – with annual values, charts, and detailed analysis.

Debt's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's SD Biosensor historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — SD Biosensor

All Key Metrics — SD Biosensor